abusesaffiliationarrow-downarrow-leftarrow-rightarrow-upattack-typeburgerchevron-downchevron-leftchevron-rightchevron-upClock iconclosedeletedevelopment-povertydiscriminationdollardownloademailenvironmentexternal-linkfacebookfiltergenderglobegroupshealthC4067174-3DD9-4B9E-AD64-284FDAAE6338@1xinformation-outlineinformationinstagraminvestment-trade-globalisationissueslabourlanguagesShapeCombined Shapeline, chart, up, arrow, graphLinkedInlocationmap-pinminusnewsorganisationotheroverviewpluspreviewArtboard 185profilerefreshIconnewssearchsecurityPathStock downStock steadyStock uptagticktooltiptwitteruniversalityweb

이 페이지는 한국어로 제공되지 않으며 English로 표시됩니다.

기사

2019년 10월 15일

저자:
CNBC (USA)

USA: Top drug distributors may settle opioid lawsuits for billions

"Top drug distributors in talks to settle opioid litigation for $18 billion, report says", 15 Oct 2019

State and local officials are reportedly in talks with three major drug distributors on a potential $18 billion settlement of litigation that blames them for helping to fuel the U.S. opioid epidemic.

The potential settlement...would require McKessonAmerisourceBergen and Cardinal Health to collectively pay the $18 billion over 18 years...

States, local governments and Native American tribes have filed some 2,000 opioid lawsuits against the distributors, drugmakers and other companies public officials say contributed to the opioid crisis...

OxyContin maker Purdue Pharma said it reached its own tentative agreement last month to settle much of its outstanding opioid litigation. The deal is going to cost the company and its billionaire owners, the Sackler family, about $10 billion...

 

타임라인